Cardiogenic Shock Clinical Trials in Montpellier
3 recruitingMontpellier, France
Showing 1–3 of 3 trials
Recruiting
Phase 3
Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock
Cardiogenic Shock
Pr Bruno LEVY610 enrolled28 locationsNCT04020263
Recruiting
IMPELLA, Complications and Tolerance
Cardiogenic Shock
University Hospital, Montpellier800 enrolled1 locationNCT06644963
Recruiting
Early Left Ventricular unLoading by Impella vs Intra-aortic Balloon Pump
Cardiogenic Shock
University Hospital, Montpellier500 enrolled1 locationNCT06645990